Close
Nordic 9Nordic 9

Carduso Capital (investor - Corporate Investor)

Netherlands cardusocapital.com
See something wrong or missing? Let us know
Offices:Groningen

Carduso Capital is a venture capital company founded by UG (University of Groningen) and UMCG (University Medical Center Groningen) from the Netherlands and backing mainly technology companies that are evolved out of the main areas of interest of this university: Life Sciences, Energy and Sustainable Society.

Average round investment:13.73M USD
Average number per year:1.5
Distribution: 2024 (2)2023 (2)2022 (1)2021 (1)
Portfolio companies: Netherlands BioBTXNetherlands QDI SystemsNetherlands EV Biotech
Mostly invests in: Netherlands Netherlands (6) Manufacturing (6)
See the entire list

Showing 3 of 6 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Carduso Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Carduso Capital

Name Criteria
United States Regeneration.VC
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Biotech, Energy, Software Services, AI (big data), Cleantech
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Germany Evonik Venture Capital GmbH
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Biotech, Energy, Software Services, Health services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Germany Edaphon
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Energy, Software Services, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Italy Diego Piacentini
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Software Services, Health services, Cleantech
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Toba Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Energy, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Netherlands Demcon
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Biotech, Software Services, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Belgium Novalis Biotech
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Biotech, Software Services, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Somerset Capital
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Energy, Software Services, Electronics
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Matrix Partners
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Biotech, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Velar Capital
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Manufacturing, Biotech, Software Services, Health services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top